Cellosaurus OMC-1 [Human ovarian carcinoma] (CVCL_9T73)

Cell line name OMC-1 [Human ovarian carcinoma]
Accession CVCL_9T73
Resource Identification Initiative To cite this cell line use: OMC-1 [Human ovarian carcinoma] (RRID:CVCL_9T73)
Comments Doubling time: 24 hours (CelloPub=CLPUB00307).
Disease Ovarian mucinous cystadenocarcinoma (NCIt: C4026)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
Publications

CLPUB00307
Hayakawa O., Tsumura N., Koizumi M., Endo T., Kudo R.
Establishment and characterization of cell line (OMC-1) derived from mucinous cystadenocarcinoma of human ovary.
Sapporo Igaku Zasshi 55:153-160(1986)

PubMed=19154404; DOI=10.1111/j.1349-7006.2008.01065.x
Sato S., Itamochi H., Kigawa J., Oishi T., Shimada M., Sato S., Naniwa J., Uegaki K., Nonaka M., Terakawa N.
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Cancer Sci. 100:546-551(2009)

PubMed=22246397; DOI=10.3892/or.2012.1626
Sato N., Saga Y., Mizukami H., Wang D., Fujiwara H., Takei Y., Machida S., Ozawa K., Suzuki M.
Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations.
Oncol. Rep. 27:1336-1340(2012)

Cross-references
Polymorphism and mutation databases Cosmic; 2429302